Vector Laboratories Announces IHC Video Training Series
BURLINGAME, Calif. (March 22, 2018) – Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, announced today the availability of its new five-part video training series on immunohistochemistry (IHC). “Become an IHC Expert (and Avoid Common Pitfalls)” will be released online this week, one segment per day, at http://info.vectorlabs.com/IHC-course-sign-up. Access to the training series is free of charge.
Topics in “Become an IHC Expert” include how to select reagents depending on experimental priorities, how to use ancillary reagents to improve results, how to optimize the protocol and when to use advanced detection protocols.
“Achieving crisp, sensitive IHC staining can be challenging,” explains Melissa Rebar, Ph.D., director of marketing for Vector Laboratories. “An important part of optimizing an immunohistochemical (IHC) assay is selecting the appropriate reagents. With this training series we help scientists understand the variables to consider when planning an experiment and choosing the reagents that satisfy the criteria. Applying the effort up front saves time, resources and potential frustrations.” The new training series is taught by Erika Leonard, director of quality control at Vector Laboratories.
About Vector Laboratories
Vector Laboratories develops, manufactures and markets labeling and detection reagents for immunohistochemistry, immunofluorescence, DNA/RNA and glycobiology. The company serves customers in disease and therapeutics research with tools that help them precisely visualize and study tissues and cells. A pioneer in a number of innovative technologies, Vector Laboratories has been providing a continuous stream of reliable tools to its customers for more than 40 years. With headquarters in Burlingame, California and a subsidiary in Peterborough, U.K., the company maintains a network of more than 40 distributors across the globe. Vector Laboratories was acquired by Maravai LifeSciences in 2016.
Contacts for the media:
David Weber, Chief Commercial Officer